Market closedRefreshes 15sData NSENot investment advice
Bayer CropScience

Bayer CropScience

NSE: BAYERCROPBSE 506285Basic Materialswww.bayer.in
View MapTV Chart
4,291.30
43.70+1.03%
DAY4,248
₹4,291.30
4,315
52W4,202
₹4,291.30
6,511
Open4,247.60
Prev Close4,247.60
Bid4,291.09100
Ask4,291.51100
Volume11.1K63%vs 20D avg
Market Cap₹19,302.63 Cr
Promoter Hold.71.4%
Face Value₹10
Fwd P/E21.64
PEG
EV/EBITDA18.26
P/S3.36
ROA8.91%
Beta0.21
Div Payout81.51%
Valuation

Bayer CropScience Ltd valuation: P/E, P/B and sector benchmarks.

Twelve years of multiples investors have paid for Bayer CropScience Ltd, framed against the sector median so the premium or discount is obvious at a glance.

Bayer CropScience Ltd trades at a P/E of 27.68× and P/B of 6.43×.

Key MetricsLive · as of 15 Jun 2026
the price tag

Valuation

Market Cap
₹19,302.63 Cr
P/E Ratio
avg27.68
P/B Ratio
watch6.43
EPS
153.34
the engine

Profitability

ROE
good23.7%
ROCE
good20.1%
Net Margin
good12.14%
Op Margin
avg13.74%
the trajectory

Growth

EPS YoY
avg13.1%
Revenue YoY
avg5.1%
Qtr Sales
avg8.95%
Qtr Profit
good125%
the balance sheet

Financial Health

Debt / Equity
watch2.76
Book Value
659.92
Div Yield
good2.94%
Promoter Hold.
good71.4%
Financials

Bayer CropScience Ltd financials: P&L, balance sheet, cash flow, ratios.

Twelve years of audited numbers for Bayer CropScience Ltd, switchable between annual and quarterly views, consolidated or standalone.

Bayer CropScience Ltd reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹19,302.63 Cr and reported EPS of ₹153.34.

all values in ₹ Cr unless suffixed · source: company filings
Segment Analysis

Bayer CropScience segment analysis: revenue and profit mix.

Disclosed business segments at Bayer CropScience with their share of revenue and profit, switchable between consolidated and standalone reporting.

Bayer CropScience discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.

Segment-wise Financial Analysis

Investment Thesis

Bayer CropScience Ltd investment thesis: bull case, bear case, and the flip lines.

Why someone would buy Bayer CropScience Ltd, why someone wouldn't, and the quantitative tripwires that would force the call to flip.

Bayer CropScience Ltd's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.

bull case

What you're getting.

  • Strong 71.4% promoter holding indicates high insider confidence and stability.

  • Robust profitability with 15.8% ROE and 20.1% ROCE.

  • Exceptional 125% quarterly profit surge demonstrates strong recent performance.

  • Very low debt-to-equity ratio of 0.04 ensures strong financial stability.

  • Diversified portfolio across agriculture and healthcare provides business resilience.

bear case

What can break it.

  • Exceptionally high P/E ratio of 443.00 suggests significant overvaluation risk.

  • Modest 4.76% Operating Profit Margin indicates potential operational inefficiencies.

  • Negative 5-day stock return of -3.58% shows recent market uncertainty.

  • Five-year Free Cash Flow CAGR of -18.75% is a liquidity concern.

  • Unsustainable 200.57% payout ratio raises questions about future dividend payments.

flip conditions

What would change my mind.

  • Trim if P/E re-rates above 36. The valuation cushion thins from there.

  • Reassess if quarterly profit growth prints below 0% for two consecutive quarters. The bull case relies on compounding earnings.

  • Watch interest coverage if debt-to-equity climbs above 3.26. Balance sheet risk re-prices growth multiples fast.

  • Exit if ROE slips below 19%. The operating engine is no longer compounding capital efficiently.

Shareholding

Bayer shareholding pattern: promoters, FII, DII and public.

Quarter-on-quarter ownership shifts in Bayer — who is buying, who is exiting, and which institutions hold the largest positions.

Shareholding Pattern

Loading shareholding data...

Peers

Bayer CropScience Ltd peer comparison — same-sector benchmarks.

Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Bayer CropScience Ltd is highlighted for quick read-across.

Technicals

Bayer CropScience Ltd technical analysis: indicators, pivots and CPR.

Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Bayer CropScience Ltd — derived from the live tape, not yesterday's close.

Bayer CropScience Ltd last traded at ₹4,291.3 with an intraday range of ₹4,247.6–₹4,315 — live indicator, pivot and CPR signals below.

Pivot points

Standard pivot — most widely referenced.

Pivot levels · Classic

Live: ₹4291.30
LevelPrice (₹)Distance% Δ
R44456.47+165.17+3.85%
R34389.07+97.77+2.28%
R24352.03+60.73+1.42%
R14321.67+30.37+0.71%
PIVOT4284.63-6.67-0.16%
CURRENT4291.30
S14119.47-171.83-4.00%
S24186.87-104.43-2.43%
S34217.23-74.07-1.73%
S44254.27-37.03-0.86%
CPR Levels
Support
Resistance
S4
S3
S2
S1
| CPR |
BC: 4281.30P: 4284.63TC: 4287.97
R1
R2
R3
R4
indicator
LTP: 4291.30
PDH: 4270.20
PDL: 4230.00
● Market Sentiment

BAYERCROP is trading Above CPR, indicating Bullishness

● CPR Width

CPR is Average

● Opening Range

Day's range: 4247.6 ~ 4315

● Price Position

Trading Above opening range, showing Bullishness

Delivery & Volume

Bayer CropScience Ltd delivery volume — last 20 sessions of conviction.

Daily traded volume and delivery percentage for Bayer CropScience Ltd over 20 sessions — the gap between intraday flipping and genuine accumulation.

Latest session delivery in Bayer CropScience Ltd stood at 51.6% of traded volume, against a 20-day average of 57.6%.

Avg Delivery (20D)57.6%-5.9 ppt latest vs avg
Highest Delivery91.8%on 09 Jun
Avg Volume (20D)29.9 K20-day run-rate
Conviction Trend↑ Strengthening-5.9 ppt latest read
Volume & Delivery · last 20 sessions
Filings & Concalls

Bayer CropScience announcements: results, concalls, ratings, M&A.

Filings Bayer CropScience sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.

No filings or concall transcripts on record.

Corporate Actions

Bayer CropScience dividend history, splits and bonus issues.

Every dividend, stock split and bonus issue Bayer CropScience has declared, sequenced by announce and record date.

Bayer CropScience corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.

About the Company

About Bayer CropScience Ltd: business, sector, key facts.

What Bayer CropScience Ltd does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.

Bayer CropScience Ltd operates in the Basic Materials, listed as NSE: BAYERCROP, BSE: 506285.

BAYERCROP
Basic Materials

Bayer CropScience Ltd

NSE · BAYERCROP·BSE · 506285·www.bayer.in

Bayer CropScience Limited is a multinational corporation primarily focused on the agricultural sector, with significant operations in India, Germany, Bangladesh, and other international markets. Its core business revolves around the research, development, manufacturing, sale, and distribution of a wide range of agrochemical products. This includes insecticides, fungicides, and herbicides designed to protect crops from pests and diseases, contributing significantly to global food security. The company also plays a key role in the seed industry, offering high-yielding hybrid seeds, notably corn and paddy, to farmers worldwide.

Beyond its agrochemical and seed offerings, Bayer CropScience is deeply involved in providing advanced digital farming solutions. These solutions leverage modern technologies like remote sensing, IoT sensors, GPS, artificial intelligence, and data analytics to optimize crop management. Specific examples include the FarmRise platform and drone services for efficient crop spraying. This commitment to technological innovation reflects a strategic aim to enhance agricultural productivity and sustainability through precise data-driven farming practices. The integration of digital technologies strengthens Bayer CropScience's position as a comprehensive agricultural solutions provider.

While the company's primary focus is agriculture, Bayer CropScience also has a presence in other healthcare-related sectors. This includes the production and distribution of pharmaceuticals across various therapeutic areas such as cardiology, gynecology, diabetes, oncology, and ophthalmology. Furthermore, it offers medical imaging equipment like computed tomography, X-ray, and magnetic resonance imaging devices. In addition to these therapeutic and diagnostic offerings, Bayer CropScience also manufactures and sells consumer health products targeted at managing minor ailments. This diversified portfolio contributes to a more resilient business model, spreading risk and providing diverse revenue streams.

The company's long history, tracing back to its founding in 1863, underscores its experience and established presence in global markets. It maintains a significant export business, further solidifying its international reach and influence. Headquartered in Thane, India, Bayer CropScience's operations are strategically positioned to address the needs of a rapidly growing global population and the ever-evolving demands of modern agriculture. The company continuously strives to improve farming efficiency and sustainability, leading to enhanced food production and a positive impact on the agricultural landscape.

company facts
Founded / IPO
Employees
SectorBasic Materials
HeadquartersThane, India
Market Cap₹19,302.63 Cr
Listed OnNSE
leadership13 on record
Dr. Thomas Hoffmann
Non-Executive Non-Independent Director
Mr. Dinesh S. Bapat
Country Group Mngr of Environmental Science for India, Sri Lanka & for Nepal
Mr. Pankaj Patel
Non-Executive Independent Chairman of the Board
Mr. Sekhar Natarajan
Non-Executive Independent Director
Mr. Simon-Thorsten Wiebusch
Chief Executive Officer, Executive Vice Chairman, Managing Director
Mr. Simon-Thorsten Wiebusch
Vice Chairman, MD & CEO
Mr. Vinit Jindal
Chief Financial Officer, Additional Whole-Time Director
Mr. Vinit Rajesh Jindal
Whole-Time Executive Director & CFO
Ms. Bharati Ratan Shetty
Company Secretary & Compliance Officer
Ms. Bharti Shetty
Compliance Officer, Company Secretary
Ms. Jana Ackermann
Non-Executive Non-Independent Director
Ms. Radhika Rajan
Non-Executive Independent Director
§ ∞ · Plainly Answered

Questions investors ask about Bayer CropScience Ltd (BAYERCROP).

Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.

01What is the current share price of Bayer CropScience Ltd (BAYERCROP)?

The current share price of Bayer CropScience Ltd (BAYERCROP) is ₹4,291.3. Today, the stock has gained by ₹43.70 (1.03%), trading in a range of ₹4,247.6 to ₹4,315. The stock opened at ₹4,247.6 with a trading volume of 11,132 shares.

02Is Bayer CropScience Ltd stock a good investment for long-term?

Bayer CropScience Ltd can be considered for long-term investment based on several factors. The company has a market capitalization of ₹19,302.63 crores, P/E ratio of 27.68, ROE of 23.70%, and ROCE of 20.10%. The dividend yield stands at 2.94%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.

03What is the 52-week high and low price of Bayer CropScience Ltd stock?

The 52-week high price of Bayer CropScience Ltd (BAYERCROP) is ₹6,511, while the 52-week low is ₹4,202.2. Currently trading at ₹4,291.3, the stock is 3.9% away from its 52-week low and 34.1% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.

04Should I buy Bayer CropScience Ltd stock at the current price?

Whether to buy Bayer CropScience Ltd stock at ₹4,291.3 depends on multiple factors. The stock is currently trading with a P/E ratio of 27.68 and P/B ratio of 6.43. Today's performance shows a gain of 1.03%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.

05What is the dividend yield of Bayer CropScience Ltd and when is the next dividend?

Bayer CropScience Ltd offers a dividend yield of 2.94%, which means for every ₹100 invested at the current price of ₹4,291.3, you can expect to receive approximately ₹2.94 annually as dividends. The face value of the stock is ₹10.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.

06What are the key financial ratios and metrics of Bayer CropScience Ltd?

Bayer CropScience Ltd's key financial metrics include: P/E Ratio: 27.68, P/B Ratio: 6.43, ROE: 23.70%, ROCE: 20.10%, Dividend Yield: 2.94%, EPS: ₹153.34, Book Value: ₹659.92, and Debt-to-Equity: 2.76. The company's market cap stands at ₹19,302.63 crores. These metrics help evaluate the company's valuation, profitability, and financial health.

07How is Bayer CropScience Ltd stock performing today in the market?

Bayer CropScience Ltd stock opened at ₹4,247.6 and is currently trading at ₹4,291.3, showing a gain of ₹43.70 (1.03%). The intraday high is ₹4,315 and low is ₹4,247.6. The trading volume stands at 11,132 shares, indicating moderate market participation today.

08What is the P/E ratio of Bayer CropScience Ltd and what does it indicate?

Bayer CropScience Ltd has a Price-to-Earnings (P/E) ratio of 27.68, which means investors are willing to pay ₹27.68 for every ₹1 of earnings. With an EPS of ₹153.34, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.

Disclaimer

The data, ratios and commentary about Bayer CropScience Ltd (BAYERCROP) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.